I last reviewed Lockheed Martin (LMT) in this January 29, 2025 post. In that post, I disclose the purchase of 50 shares @ $457.75 in one of the 'Core' accounts in the FFJ Portfolio on January 28. This purchase increased my exposure to 620 shares. With the automatic reinvestment of dividend income, my exposure is [...]
There are no material changes subsequent to my October 25, 2025 post. The purpose of this brief post, therefore, is merely to disclose the purchase of an additional 100 shares @ $266.875 on January 6, 2026 in a 'Core' account in the FFJ Portfolio. Dividends and Share Repurchases Dividend and Dividend Yield The following is [...]
I last reviewed Veeva Systems (VEEV) in this November 21, 2025 post at which time the Q3 and YTD2026 results had just been released following the November 20, 2025 market close. At the end of Q3, the company had ~$1.66B in cash and cash equivalents and ~$4.977B in short-term investments. Meanwhile, its total liabilities amounted to [...]
In my June 9, 2025 post I disclose my decision to acquire an additional 500 shares in Howard Hughes Holdings (HHH) after disclosing a 500 share position in the FFJ Portfolio in my June 3 post. In these two posts I touch upon how HHH is about to undergo a radical transformation. This transformation includes [...]
In my September 24, 2025 post, I disclose the purchase of an additional 100 shares @ $200.79 bringing my total exposure to 600 shares in a 'Side' account in the FFJ Portfolio. When I wrote that post, CTAS had just released its Q1 2026 results. Subsequently, an improvement in valuation prompted me to acquire an [...]
In this December 3, 2025 post, I disclose my decision to initiate a 200 share position in Arista Networks (ANET) @ $127.505/share on December 2, 2025 in one of the 'Core' accounts in the FFJ Portfolio. I acquired an additional 200 shares @ $128.01/share in the same account on December 5 bringing my ANET exposure [...]
I last reviewed HEICO (HEI and HEI-a) in this August 26, 2025 post at which time it had just released Q3 and YTD2025 results. With the release of Q4 and FY2025 results following the December 18 market close, I revisit this existing holding to gauge its valuation. I initiated a position in September 2019 and [...]
My last Accenture (ACN) review is in this September 26, 2025 post following the release of FY2025 results. In that post I disclose my September 25 purchase of 100 shares @ ~$236.25. With the release of Q1 2026 results and updated FY2026 guidance on December 18, I revisit this existing holding. Business Overview ACN is [...]
In my December 3, 2025 post, I state my preference to invest in wide moat, profitable, and undervalued/fairly valued growing companies that generate strong earnings and free cash flow. Companies with no debt (or exceptionally low debt levels) are particularly attractive. Such investment opportunities sometimes present themselves when great companies fall temporarily out of favor [...]
I initiated a 300 share Cintas (CTAS) position in a 'Side' account within the FFJ Portfolio in December 2024. I disclose this purchase in this December 19, 2024 post. On January 7, 2025, CTAS announced that it submitted a proposal to UniFirst Corporation's (UNF) Board to acquire all outstanding common and class B shares [...]
